BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 9506575)

  • 1. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.
    Menon N; McAlpine L; Peacock AJ; Madhok R
    Arthritis Rheum; 1998 Mar; 41(3):466-9. PubMed ID: 9506575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vasodilator agents in pulmonary artery hypertension of systemic scleroderma].
    Phlippoteau C; Brenot F; Blétry O; Simmonneau G; Duroux P
    Rev Mal Respir; 1990; 7(3):249-54. PubMed ID: 2114030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension.
    Krowka MJ; Frantz RP; McGoon MD; Severson C; Plevak DJ; Wiesner RH
    Hepatology; 1999 Sep; 30(3):641-8. PubMed ID: 10462369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
    Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
    J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary hypertension in systemic lupus erythematosus: effect of vasodilators on pulmonary hemodynamics.
    Mahowald ML; Weir EK; Ridley DJ; Messner RP
    J Rheumatol; 1985 Aug; 12(4):773-7. PubMed ID: 4057200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute hemodynamic effects of ketanserin in pulmonary hypertension secondary to systemic sclerosis.
    Seibold JR; Molony RR; Turkevich D; Ruddy MC; Kostis JB
    J Rheumatol; 1987 Jun; 14(3):519-24. PubMed ID: 3625632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tolazoline and prostacyclin on pulmonary hypertension in infants after cardiac surgery.
    Schranz D; Zepp F; Iversen S; Wippermann C; Huth R; Zimmer B; Jüngst BK; Oelert H
    Crit Care Med; 1992 Sep; 20(9):1243-9. PubMed ID: 1521438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacology of the pulmonary circulation].
    Follath F
    Schweiz Med Wochenschr; 1985 Sep; 115(39):1328-32. PubMed ID: 2866581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary vasodilation after heart transplantation. A comparison among prostacyclin, sodium nitroprusside, and nitroglycerin on right ventricular function and pulmonary selectivity.
    Kieler-Jensen N; Milocco I; Ricksten SE
    J Heart Lung Transplant; 1993; 12(2):179-84. PubMed ID: 8476888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of acute pulmonary hypertension by prostacyclin.
    Borchert J; Franke J; Lichey J
    Cor Vasa; 1980; 22(4):281-7. PubMed ID: 7004773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in vasoconstrictor pulmonary hypertension in sheep.
    Prielipp RC; Rosenthal MH; Pearl RG
    Anesth Analg; 1988 Aug; 67(8):722-9. PubMed ID: 3293483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute effect of the synthetic prostacyclin analogue iloprost in primary pulmonary hypertension.
    Scott JP; Higenbottam T; Wallwork J
    Br J Clin Pract; 1990 Jun; 44(6):231-4. PubMed ID: 1698429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the effects of vasodilator therapy in primary pulmonary hypertension. Experience in 7 cases].
    Lanzarini L; Gavazzi A; Mussini A; Graziano G; Campana C; Bargiggia G; Angoli L; Aimè E; Arbustini E; Montemartini C
    G Ital Cardiol; 1990 Feb; 20(2):114-22. PubMed ID: 2328864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of the calcium antagonist nifedipine on central and peripheral hemodynamics in patients with primary pulmonary hypertension].
    Khosseĭn A; Mareev VIu; Ageev FT; Sazonova LN; Lobova NM
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(1):78-81. PubMed ID: 3401345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of pimobendan on pulmonary hypertension in patients with chronic pulmonary emphysema].
    Yamazaki Y; Matsumoto H; Takeda A; Takahashi T; Sasaki N; Takahashi M; Tsuji T; Fujikane T; Shimizu T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Aug; 35(8):847-53. PubMed ID: 9366158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of acute and chronic effects of nifedipine in patients with secondary pulmonary hypertension].
    Dubiel JP; Nikodemowicz M; Zmudka K; Mazurek S; Królikowski T
    Kardiol Pol; 1991; 34(5):279-86. PubMed ID: 1921110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous therapy with intravenous prostacyclin for primary pulmonary hypertension: a bridge to heart-lung transplantation.
    Kramer MR; Fucks S; Simon Z; Berkman N
    Isr J Med Sci; 1993 Oct; 29(10):613-6. PubMed ID: 8244657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of primary pulmonary hypertension with phentolamine].
    Heinrich U; Angehrn W; Steinbrunn W
    Schweiz Med Wochenschr; 1983 Jan; 113(4):145-8. PubMed ID: 6828847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient effect of nifedipine on pulmonary hypertension of systemic sclerosis.
    Fudman EJ; Kelling DG
    J Rheumatol; 1985 Dec; 12(6):1191-2. PubMed ID: 4093929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension.
    Rubin LJ; Groves BM; Reeves JT; Frosolono M; Handel F; Cato AE
    Circulation; 1982 Aug; 66(2):334-8. PubMed ID: 7046988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.